Accelerate Diagnostics, Inc SEC Filings

Filed On	Filing
18 Aug 2025	NT 10-Q
18 Aug 2025	8-K: Entry into a Material Definitive Agreement; Bankruptcy or Receivership +1 more
21 Jul 2025	25-NSE
25 Jun 2025	Form 3: Nathan Gilbert E, Director No securities owned
04 Jun 2025	8-K: Entry into a Material Definitive Agreement
28 May 2025	8-K: Departure/Election of Directors or Officers; Compensation
16 May 2025	NT 10-Q
15 May 2025	SCHEDULE 13G/A
12 May 2025	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
08 May 2025	8-K: Entry into a Material Definitive Agreement; Bankruptcy or Receivership +4 more
01 May 2025	Form 3: Shalhoub Paul Vincent, Director No securities owned
30 Apr 2025	10-K/A
25 Apr 2025	8-K: Departure/Election of Directors or Officers; Compensation
15 Apr 2025	8-K: Departure/Election of Directors or Officers; Compensation
07 Apr 2025	Form 4: Phillips Jack, Director Received 53,283 shares by exercise or conversion · Sold 25,343 shares ($16.5K)
07 Apr 2025	Form 4: Mertz Larry Michael, Chief Technology Officer Received 4,298 shares by exercise or conversion · Sold 1,523 shares ($990)
02 Apr 2025	Form 4: Patience David, Chief Financial Officer Received 20,000 shares by exercise or conversion · Sold 6,816 shares ($4.84K)
21 Mar 2025	8-K: Other Events
21 Mar 2025	8-K: Results of Operations and Financial Condition
21 Mar 2025	10-K

Comments